Questions: Innate Lymphoid Cells and Barrier Immunity

Question 1

ILC3s protect mucosal barriers primarily through which mechanism?

• A. Directly killing pathogens through perforin and granzyme-mediated cytotoxicity
• B. Presenting antigen on MHC class II to activate CD4+ T helper cells
• C. Producing IL-22, which strengthens epithelial tight junctions and stimulates antimicrobial peptide production
• D. Secreting IFN-γ to activate macrophages in the lamina propria

Answer: (C)

ILC3s protect barrier surfaces through IL-22, which acts on epithelial cells to reinforce tight junctions (preventing microbial penetration), stimulate antimicrobial peptides like RegIIIγ and defensins, and promote epithelial proliferation for tissue repair. IL-22 is the signature cytokine of ILC3s, paralleling the Th17 subset. Option D describes the ILC1/Th1 axis (IFN-γ); option A describes NK cell function; option B describes dendritic cells and adaptive immunity.

Question 2

In a neonate whose adaptive immune system is still maturing, a gut pathogen begins breaching the epithelial barrier. Which cell type is most positioned to provide rapid cytokine-mediated defense at this mucosal site?

• A. CD4+ T helper cells from Peyer's patches
• B. Plasma B cells secreting IgA into the gut lumen
• C. ILC3s already resident in the gut mucosa
• D. Dendritic cells rapidly migrating from bone marrow

Answer: (C)

ILCs are tissue-resident cells pre-positioned at mucosal barriers. They do not require antigen-specific priming — they respond to cytokines and alarmins from epithelial cells within hours. In neonates, whose adaptive T and B cell responses are still developing, ILCs are particularly critical for mucosal defense. Adaptive responses (options A and B) require days of activation, expansion, and migration. Option D is wrong because dendritic cells do not rapidly deploy from bone marrow in this context.

Question 3

ILCs produce cytokines that parallel T helper subset profiles but do so without rearranged antigen receptors, making them functionally innate despite their lymphoid lineage.

• T. True
• F. False

Answer: True

This parallel is the defining concept: ILC1s produce IFN-γ like Th1; ILC2s produce IL-5 and IL-13 like Th2; ILC3s produce IL-17 and IL-22 like Th17. Each group shares transcription factors with its T helper analog (ILC1: T-bet; ILC2: GATA-3; ILC3: RORγt). But ILCs lack the rearranged TCRs that make T cells antigen-specific. They activate through pattern recognition signals, cytokines, and alarmins rather than through antigen-MHC engagement — hence 'functionally innate' despite being lymphocytes.

Question 4

Because ILCs lack rearranged antigen receptors, they can seldom respond directly to tissue signals and is expected to be activated by other immune cells presenting antigens.

• T. True
• F. False

Answer: False

ILCs do not require antigen-presenting cells or antigen-specific activation. They respond directly to cytokines and alarmins released by damaged or infected epithelial cells — for example, IL-33, IL-25, and TSLP activate ILC2s; IL-1β and IL-23 activate ILC3s. This signal independence is the key to their speed advantage: they are pre-positioned in tissue and can begin secreting cytokines within hours of epithelial breach, without waiting for the activation, expansion, and migration that adaptive responses require.

Question 5

What is the functional advantage of having tissue-resident ILCs at mucosal surfaces rather than relying entirely on T cell-based adaptive immunity for barrier protection?

Model answer: ILCs provide speed: they are already stationed at mucosal barrier sites and respond to tissue-derived signals (alarmins, cytokines) within hours, without the days required for naïve T cells to be activated, expanded, and homed to the site. This rapid first-line response is especially critical at surfaces exposed to constant microbial challenge (gut, lungs, skin), and in populations such as neonates whose adaptive immune systems are still developing. ILCs hold the line until adaptive immunity can mobilize.

This speed-versus-specificity tradeoff is central to immunology: adaptive immunity provides exquisite precision but requires days; innate mechanisms sacrifice specificity for immediacy. ILCs occupy an interesting position — they are lymphocytes with tissue-specific programs calibrated to the likely threats at each barrier site, providing a tailored but pre-set response. This makes them qualitatively different from generic innate responders like neutrophils or macrophages.